Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Foussat

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Gastroenterology|August 14, 2012
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseasePierre Desreumaux, Arnaud Foussat, Matthieu Allez, et al.
Cytotherapy|April 23, 2013
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpointsLisbeth Barkholt, Egbert Flory, Veronika Jekerle, et al.
Frontiers in Immunology|November 21, 2022
Relationships of circulating CD4<sup>+</sup> T cell subsets and cytokines with the risk of relapse in patients with Crohn's diseaseRémi Duclaux-Loras, Gilles Boschetti, Bernard Flourie, et al.
Cancer Research|June 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast CancerStéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Gastroenterology|August 14, 2012
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseasePierre Desreumaux, Arnaud Foussat, Matthieu Allez, et al.
Cytotherapy|April 23, 2013
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpointsLisbeth Barkholt, Egbert Flory, Veronika Jekerle, et al.
Frontiers in Immunology|November 21, 2022
Relationships of circulating CD4<sup>+</sup> T cell subsets and cytokines with the risk of relapse in patients with Crohn's diseaseRémi Duclaux-Loras, Gilles Boschetti, Bernard Flourie, et al.
Cancer Research|June 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast CancerStéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Pageof 3